Dr Sudhir Ranjan Pattanaik

Dr Sudhir Ranjan Pattanaik

Professor & HOD

Dr Sudhir Ranjan Pattanaik

Professor & HOD
OCMR Regd. No.:
Email: drsrpatnaik@gmail.com
Permanent Address: Sailajyoti Bhawan, Kathagola, Manglabag, Cuttack , Odisha- 753001
Correspondence Address: Sailajyoti Bhawan, Kathagola, Manglabag, Cuttack , Odisha- 753001
Course Name Name of PG Degree Area of Specialization/ Specialty Year of Qualifying degree Name of University / Institute
MBBS 1984 SCBMCH, Cuttack, Utkal University
PG Degree General Medicine 1987 MKCG MCH, Berhampur
Post Doctoral Qualification Endocrinology 1995 PGI Chandigarh

List of Publications (separate list may be attached if required): Of Last 10 Years

  1. Aruna, M., Kumar, P.R., Dash, D.K., Pattanaik, S.R et.al . Prospective study of clinical, biochemical, and radiological characteristics of diabetic Charcot neuroarthropathy at a tertiary care centre. Int J Diabetes Dev Ctries (2023). https://doi.org/10.1007/s13410
  2. Gandhi, Ronak; Kumar, Padala Ravi; Pattanaik, Sudhi R.; Sahoo, Devadarshini. Effect of Testosterone Undecanoate on Sexual Functions, Glycaemic Parameters, and Cardiovascular Risk Factors in Hpogonadal Men with Type 2 Diabetes Mellitus. Indian Journal of Endocrinology and Metabolism 26(6):p 565
  3. Sahoo D, Pattanaik RS, Kumar PR, Gandhi R. Role of serum irisin during early pregnancy to predict the development of gestational diabetes mellitus at 24-28 weeks of pregnancy in high-risk patients. Indian J EndocrMetab 2022:26:61-7
  4. Kumar PR, Chatterjee A, Behera JP, Patnaik S. Effect of sertraline as an add-on therapy in T2DM patients with comorbid depression: An open label randomized trolled trial. Indian J EndocrMetab 2019;23:357-62.
  5. Kumar PR, Palo 1, Pattanaik SR. Cardiovascular and atherogenic risk profile in young Indian PCOS Patients.
    Panacea J Med Sci 2020;10(3):1-4
  6. S R Pattanaik, Padala Ravi Kumar. Efficacy and safety of addition of empagliflozin in diabetic patients uncontrolled with triple therapy glimepride/metformin and sitagliptin. International Journal of Contemporary Medicine
    Surgery and Radiology. 2020;5(3):c26
  7. Pattanaik SR. Safety and efficacy of cabergoline on pregnancy outcome in patients with microprolactinoma. J. Evid. Based Med.
    Healthc. 2018; 5(25), 1877-1880
  8. Efficacy of canagliflozin as an add-on to triple drug treatment with glimepiride, metformin and teneligliptin.
    J. Evid. Based Med. Healthc. 2018; 5(27), 2042-2046
  9. S.R. Pattanaik. Efficacy of addition of remogliflozin to type-2 diabetic patients, uncontrolled with dual drug treatment with metformin and glimeperide, an observational study. International Journal of Contemporary
    Medicine Surgery and Radiology. 2020;5(3):C1-C3
  10. 11. Baidya A, Pattanaik SR, Shankar A et.al. Efficacy and safety of Hydroxychloroquine as an add on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with two oral drug combination and basal insulin: a 72 week observational trial. International Journal of Research and Review. 2019; 6(11):218-224
  11. SR. A hospital based study to evaluate the prevalence of diabetic nephropathy by considering microalbuminuria as early risk marker in type 2 diabetic subjects. International Journal of Research and Review. 2019; 6(12):523-526
  12. Dr SR Patnaik, Efficacy and safety of addition of Teneligliptin to Type 2 Diabetes patients inadequately controlled with triple drug treatment with Glimepride+Metformin+Voglibose.JMSCR; 2018;p 2455-0450

Professional Membership (If any):

  1. API, RSSDI, ESI, AACE
  2. Research Experience: 30 years